Shailja Singh Selected Research

Shailja Singh Research Topics

Disease

44	Malaria 09/2022 - 01/2007
5	Infections 01/2022 - 01/2021
4	Neoplasms (Cancer) 12/2021 - 06/2017
3	Breast Neoplasms (Breast Cancer) 06/2017 - 01/2016
2	Hemolysis 09/2022 - 10/2019
2	Visceral Leishmaniasis (Kala Azar) 06/2022 - 01/2018
2	Leishmaniasis 06/2022 - 01/2022
2	Neuroinflammatory Diseases 01/2022 - 10/2021
2	Inflammation (Inflammations) 01/2022 - 11/2018
2	Glioma (Gliomas) 04/2005 - 12/2004
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2022
1	Insulin Resistance 01/2022
1	Glucosephosphate Dehydrogenase Deficiency 10/2021
1	Autism Spectrum Disorder 10/2021
1	Hepatocellular Carcinoma (Hepatoma) 09/2021
1	Hypertension (High Blood Pressure) 05/2021
1	Tuberculosis (Tuberculoses) 01/2021
1	Necrosis 01/2021
1	Cerebral Malaria 12/2020
1	Diabetes Mellitus 07/2020
1	Anemia 01/2020
1	Communicable Diseases (Infectious Diseases) 10/2019
1	Parasitemia 07/2019
1	Body Weight (Weight, Body) 10/2016

Drug/Important Bio-Agent (IBA)

15	Pharmaceutical PreparationsIBA 01/2022 - 01/2013
11	Antimalarials (Antimalarial Agents)IBA 01/2022 - 05/2012
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2013
5	VaccinesIBA 01/2022 - 02/2012
5	LigandsIBA 12/2015 - 12/2004
4	AntigensIBA 01/2022 - 06/2013
4	Biological ProductsIBA 11/2019 - 01/2016
3	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 05/2021 - 01/2020
3	CalciumIBA 04/2019 - 01/2013
2	AutoantibodiesIBA 02/2022 - 07/2016
2	Malaria VaccinesIBA 01/2022 - 11/2018
2	quinolineIBA 01/2022 - 10/2016
2	LipidsIBA 01/2022 - 01/2019
2	Insulin (Novolin)FDA Link 01/2022 - 07/2020
2	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2020
2	Peptide Hydrolases (Proteases)FDA Link 02/2021 - 01/2019
2	artemisinin (artemisinine)IBA 01/2021 - 07/2019
2	ArtesunateIBA 10/2020 - 07/2019
2	PerforinIBA 12/2015 - 01/2013
2	DNA (Deoxyribonucleic Acid)IBA 04/2005 - 12/2004
1	phthalimideIBA 09/2022
1	benzimidazoleIBA 09/2022
1	PhthalimidesIBA 09/2022
1	TubulinIBA 09/2022
1	Transfer RNA (tRNA)IBA 06/2022
1	Peptides (Polypeptides)IBA 06/2022
1	Immunoglobulins (Immunoglobulin)IBA 02/2022
1	Complement System Proteins (Complement)IBA 02/2022
1	AminoquinolinesIBA 01/2022
1	prefoldinIBA 01/2022
1	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2022
1	Quinine (Quinson)FDA Link 01/2022
1	Subunit VaccinesIBA 01/2022
1	Amyloid beta-PeptidesIBA 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2021
1	coumarinIBA 12/2021
1	Glucose (Dextrose)FDA LinkGeneric 10/2021
1	Oxidoreductases (Dehydrogenase)IBA 10/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2021
1	Carotenoids (Carotene)IBA 09/2021
1	Antihypertensive Agents (Antihypertensives)IBA 05/2021
1	Angiotensin IIIBA 05/2021
1	BradykininIBA 05/2021
1	Trinitrotoluene (TNT)IBA 01/2021
1	NAD+ Nucleosidase (NAD(P) Nucleosidase)IBA 01/2021
1	NAD (NADH)IBA 01/2021
1	SphingolipidsIBA 01/2021
1	HMGB1 Protein (HMG1)IBA 01/2021
1	chorismate synthaseIBA 12/2020
1	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 12/2020
1	Cold Shock Proteins and PeptidesIBA 10/2020
1	graphene oxideIBA 10/2020
1	ferric oxide (iron oxide)IBA 10/2020
1	HLA-DQ Antigens (HLA-DQ)IBA 07/2020
1	Protein SIBA 01/2020
1	2-bromopalmitateIBA 01/2020
1	LactamsIBA 11/2019
1	indoleIBA 11/2019
1	AlkaloidsIBA 11/2019
1	Chloroquine (Aralen)FDA LinkGeneric 11/2019
1	galactalIBA 10/2019
1	BenzoxazinesIBA 04/2019
1	EugenolIBA 04/2019
1	GraphiteIBA 04/2019
1	Phosphatidic Acids (Phosphatidic Acid)IBA 01/2019
1	Phosphatidate PhosphataseIBA 01/2019
1	Phospholipases (Phospholipase)IBA 01/2019
1	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2018
1	Toll-Like Receptor AgonistsIBA 11/2018
1	AcyltransferasesIBA 01/2018
1	Amodiaquine (Camoquin)FDA Link 10/2016
1	Composite ResinsIBA 08/2016
1	Polyethylene (Polythene)IBA 08/2016

Therapy/Procedure

11	Therapeutics 01/2022 - 06/2017
3	Drug Therapy (Chemotherapy) 01/2022 - 11/2014
1	Precision Medicine 10/2021